Evidence map›Paper›PMID 21160866›Full record

ArticleWorld journal of gastrointestinal surgery2010

NOTES new frontier: Natural orifice approach to retroperitoneal disease.

Pierre Allemann, Silvana Perretta, Mitsuhiro Asakuma, Bernard Dallemagne, Jacques Marescaux

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastrointestinal surgery, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Pierre AllemannPierre Allemann, Silvana Perretta, Mitsuhiro Asakuma, Bernard Dallemagne, Jacques Marescaux, IRCAD/EITS Institute, Strasbourg University Hospital, 1, place de l'hôpital, 67000 Strasbourg, France.
Silvana Perretta
Mitsuhiro Asakuma
Bernard Dallemagne
Jacques Marescaux
Institut de Recherche contre les Cancers de l’Appareil Digestif · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo develop a pure transvaginal access to the retroperitoneum, that is simple, reproducible and uses endoscopic material available on the market.

methodsFrom February 2008 to April 2009, 31 pigs were operated on, with 17 as an acute experiment and 14 with a survival protocol. The animals were placed in a supine position and a 12-mm double-channel endoscope (Karl Storz™, Tuttlingen) was used for vision and dissection. During the same time period, the access experiment was reproduced on 3 human cadavers using material similar to that used in the animal model.

resultsIn the animal model, 37 interventions were done on the kidney, adrenal gland and pancreas. The mean time to fashion the access was 10 min (range 5 to 20 min). No intraoperative death was observed. Two major (5%) intraoperative complications occurred: one hemorrhage on the aorta and one tearing of the right renal vein. Peritoneal laceration was encountered in 5 cases without impairing the planned task. In the survival group, good clinical outcome was observed at a mean follow-up of 3 wk (range 2 to 6 wk). In the 3 cadavers, access was performed correctly. The mean time to fashion the access was 52 min (range 40 to 60 min). All the anatomical landmarks described in the pig model were clearly identified in the same sequence.

conclusionA retroperitoneal natural orifice translumenal surgical transvaginal approach is feasible in both animal and human models and allows performance of a large panel of interventions.

Indexed as

AdrenalectomyNatural orificeNatural orifice translumenal surgeryNephrectomyPancreatectomyRetroperitoneum

Identifiers

PMID21160866
PMCPMC2999234
OpenAlexW2077615579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.